- JP-listed companies
- PhoenixBio Co.,Ltd.
- Financials
- Net income margin (%)
PhoenixBio Co.,Ltd. (6190)
Market cap
¥1.5B
P/E ratio
19.6x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
| Period End | Net income margin (%) (Million JPY) | YoY (%) |
|---|